Local and intralesional therapy of in-transit melanoma metastases. 2011

Alessandro Testori, and Mark B Faries, and John F Thompson, and E Pennacchioli, and Jan P Deroose, and Albertus N van Geel, and Cornelis Verhoef, and Francesco Verrecchia, and Javier Soteldo
Melanoma and Sarcoma Division, European Institute of Oncology, Milan, Italy. alessandro.testori@ieo.it

Regional relapse of melanoma may occur as satellite or in-transit metastases proximal to the primary tumor in the direction of the lymph flow. The management of in-transit metastases is challenging because the efficacy of treatment is largely dictated by the biological behavior of the patient's melanoma. This review examines local treatment modalities.

UI MeSH Term Description Entries
D007167 Immunotherapy Manipulation of the host's immune system in treatment of disease. It includes both active and passive immunization as well as immunosuppressive therapy to prevent graft rejection. Immunotherapies
D008207 Lymphatic Metastasis Transfer of a neoplasm from its primary site to lymph nodes or to distant parts of the body by way of the lymphatic system. Lymph Node Metastasis,Lymph Node Metastases,Lymphatic Metastases,Metastasis, Lymph Node
D008545 Melanoma A malignant neoplasm derived from cells that are capable of forming melanin, which may occur in the skin of any part of the body, in the eye, or, rarely, in the mucous membranes of the genitalia, anus, oral cavity, or other sites. It occurs mostly in adults and may originate de novo or from a pigmented nevus or malignant lentigo. Melanomas frequently metastasize widely, and the regional lymph nodes, liver, lungs, and brain are likely to be involved. The incidence of malignant skin melanomas is rising rapidly in all parts of the world. (Stedman, 25th ed; from Rook et al., Textbook of Dermatology, 4th ed, p2445) Malignant Melanoma,Malignant Melanomas,Melanoma, Malignant,Melanomas,Melanomas, Malignant
D009163 Mycobacterium bovis The bovine variety of the tubercle bacillus. It is called also Mycobacterium tuberculosis var. bovis. BCG,Calmette-Guerin Bacillus
D011878 Radiotherapy The use of IONIZING RADIATION to treat malignant NEOPLASMS and some benign conditions. Radiotherapy, Targeted,Targeted Radiotherapy,Radiation Therapy,Radiation Therapy, Targeted,Radiation Treatment,Targeted Radiation Therapy,Radiation Therapies,Radiation Therapies, Targeted,Radiation Treatments,Radiotherapies,Radiotherapies, Targeted,Targeted Radiation Therapies,Targeted Radiotherapies,Therapies, Radiation,Therapies, Targeted Radiation,Therapy, Radiation,Therapy, Targeted Radiation,Treatment, Radiation
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000287 Administration, Topical The application of drug preparations to the surfaces of the body, especially the skin (ADMINISTRATION, CUTANEOUS) or mucous membranes. This method of treatment is used to avoid systemic side effects when high doses are required at a localized area or as an alternative systemic administration route, to avoid hepatic processing for example. Drug Administration, Topical,Administration, Topical Drug,Topical Administration,Topical Drug Administration,Administrations, Topical,Administrations, Topical Drug,Drug Administrations, Topical,Topical Administrations,Topical Drug Administrations
D000970 Antineoplastic Agents Substances that inhibit or prevent the proliferation of NEOPLASMS. Anticancer Agent,Antineoplastic,Antineoplastic Agent,Antineoplastic Drug,Antitumor Agent,Antitumor Drug,Cancer Chemotherapy Agent,Cancer Chemotherapy Drug,Anticancer Agents,Antineoplastic Drugs,Antineoplastics,Antitumor Agents,Antitumor Drugs,Cancer Chemotherapy Agents,Cancer Chemotherapy Drugs,Chemotherapeutic Anticancer Agents,Chemotherapeutic Anticancer Drug,Agent, Anticancer,Agent, Antineoplastic,Agent, Antitumor,Agent, Cancer Chemotherapy,Agents, Anticancer,Agents, Antineoplastic,Agents, Antitumor,Agents, Cancer Chemotherapy,Agents, Chemotherapeutic Anticancer,Chemotherapy Agent, Cancer,Chemotherapy Agents, Cancer,Chemotherapy Drug, Cancer,Chemotherapy Drugs, Cancer,Drug, Antineoplastic,Drug, Antitumor,Drug, Cancer Chemotherapy,Drug, Chemotherapeutic Anticancer,Drugs, Antineoplastic,Drugs, Antitumor,Drugs, Cancer Chemotherapy
D012878 Skin Neoplasms Tumors or cancer of the SKIN. Cancer of Skin,Skin Cancer,Cancer of the Skin,Neoplasms, Skin,Cancer, Skin,Cancers, Skin,Neoplasm, Skin,Skin Cancers,Skin Neoplasm
D015552 Injections, Intralesional Injections introduced directly into localized lesions. Intralesional Injections,Injection, Intralesional,Intralesional Injection

Related Publications

Alessandro Testori, and Mark B Faries, and John F Thompson, and E Pennacchioli, and Jan P Deroose, and Albertus N van Geel, and Cornelis Verhoef, and Francesco Verrecchia, and Javier Soteldo
April 2015, Surgical oncology clinics of North America,
Alessandro Testori, and Mark B Faries, and John F Thompson, and E Pennacchioli, and Jan P Deroose, and Albertus N van Geel, and Cornelis Verhoef, and Francesco Verrecchia, and Javier Soteldo
June 2021, Melanoma research,
Alessandro Testori, and Mark B Faries, and John F Thompson, and E Pennacchioli, and Jan P Deroose, and Albertus N van Geel, and Cornelis Verhoef, and Francesco Verrecchia, and Javier Soteldo
March 2014, Journal of surgical oncology,
Alessandro Testori, and Mark B Faries, and John F Thompson, and E Pennacchioli, and Jan P Deroose, and Albertus N van Geel, and Cornelis Verhoef, and Francesco Verrecchia, and Javier Soteldo
July 2019, International journal of dermatology,
Alessandro Testori, and Mark B Faries, and John F Thompson, and E Pennacchioli, and Jan P Deroose, and Albertus N van Geel, and Cornelis Verhoef, and Francesco Verrecchia, and Javier Soteldo
January 1992, Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete,
Alessandro Testori, and Mark B Faries, and John F Thompson, and E Pennacchioli, and Jan P Deroose, and Albertus N van Geel, and Cornelis Verhoef, and Francesco Verrecchia, and Javier Soteldo
September 2009, Actas dermo-sifiliograficas,
Alessandro Testori, and Mark B Faries, and John F Thompson, and E Pennacchioli, and Jan P Deroose, and Albertus N van Geel, and Cornelis Verhoef, and Francesco Verrecchia, and Javier Soteldo
December 2012, Melanoma research,
Alessandro Testori, and Mark B Faries, and John F Thompson, and E Pennacchioli, and Jan P Deroose, and Albertus N van Geel, and Cornelis Verhoef, and Francesco Verrecchia, and Javier Soteldo
February 2004, Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete,
Alessandro Testori, and Mark B Faries, and John F Thompson, and E Pennacchioli, and Jan P Deroose, and Albertus N van Geel, and Cornelis Verhoef, and Francesco Verrecchia, and Javier Soteldo
March 2016, JAAD case reports,
Alessandro Testori, and Mark B Faries, and John F Thompson, and E Pennacchioli, and Jan P Deroose, and Albertus N van Geel, and Cornelis Verhoef, and Francesco Verrecchia, and Javier Soteldo
December 2023, Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.],
Copied contents to your clipboard!